Pandox Crecimiento futuro

Future controles de criterios 4/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Pandox de 46.3% y 2.2% respectivamente, mientras que el BPA crecerá en un 1.8% al año.

Información clave

46.3%

Tasa de crecimiento de los beneficios

46.4%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Real Estate	67.2%
Tasa de crecimiento de los ingresos	2.2%
Rentabilidad financiera futura	n/a
Cobertura de analistas	Low
Última actualización	25 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Industry Analysts Just Upgraded Their Pandox AB (publ) (STO:PNDX B) Revenue Forecasts By 16%

Oct 28

Is Pandox (STO:PNDX B) Using Too Much Debt?

Sep 26

We Think Pandox (STO:PNDX B) Is Taking Some Risk With Its Debt

May 30

Analysts Just Made A Stunning Upgrade To Their Pandox AB (publ) (STO:PNDX B) Forecasts

Feb 12

Pandox (STO:PNDX B) Has A Somewhat Strained Balance Sheet

Jan 15

Pandox (STO:PNDX B) Use Of Debt Could Be Considered Risky

Sep 18

Pandox (STO:PNDX B) May Have Issues Allocating Its Capital

Jun 27

Pandox (STO:PNDX B) Seems To Be Using A Lot Of Debt

May 31

Our Take On The Returns On Capital At Pandox (STO:PNDX B)

Mar 11

What Type Of Returns Would Pandox's(STO:PNDX B) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Feb 02

Based On Its ROE, Is Pandox AB (publ) (STO:PNDX B) A High Quality Stock?

Jan 12

Pandox (STO:PNDX B) Use Of Debt Could Be Considered Risky

Dec 22

Will Pandox (STO:PNDX B) Multiply In Value Going Forward?

Nov 30

Previsiones de crecimiento de beneficios e ingresos

OM:PNDX B - Estimaciones futuras de los analistas y datos financieros pasados (SEK Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	7,412	1,543	743	1,950	1
12/31/2025	7,142	1,571	706	1,898	1
12/31/2024	6,962	1,647	1,125	1,589	1
3/31/2024	6,997	78	1,596	1,643	N/A
12/31/2023	6,849	-585	2,146	2,193	N/A
9/30/2023	6,774	648	2,190	2,222	N/A
6/30/2023	6,306	1,875	2,603	2,635	N/A
3/31/2023	6,014	2,959	2,579	2,611	N/A
12/31/2022	5,537	4,217	2,345	2,377	N/A
9/30/2022	4,740	4,355	2,037	2,134	N/A
6/30/2022	4,069	2,988	1,308	1,405	N/A
3/31/2022	3,389	1,611	827	924	N/A
12/31/2021	3,247	610	333	430	N/A
9/30/2021	2,968	51	394	461	N/A
6/30/2021	2,850	-368	350	417	N/A
3/31/2021	2,821	-691	83	150	N/A
12/31/2020	3,178	-1,399	393	460	N/A
9/30/2020	3,946	198	368	478	N/A
6/30/2020	4,598	543	841	951	N/A
3/31/2020	5,453	1,632	1,313	1,423	N/A
12/31/2019	5,553	2,706	1,824	1,934	N/A
9/30/2019	5,473	2,185	2,283	2,348	N/A
6/30/2019	5,363	2,776	1,823	1,888	N/A
3/31/2019	5,263	2,777	2,010	2,075	N/A
12/31/2018	5,124	2,820	1,645	1,710	N/A
9/30/2018	4,848	3,232	1,557	1,685	N/A
6/30/2018	4,559	2,945	1,749	1,877	N/A
3/31/2018	4,326	3,068	1,550	1,678	N/A
12/31/2017	4,269	3,140	N/A	1,693	N/A
9/30/2017	4,247	2,719	N/A	1,306	N/A
6/30/2017	4,235	2,761	N/A	1,286	N/A
3/31/2017	4,112	2,349	N/A	1,242	N/A
12/31/2016	3,945	2,201	N/A	1,195	N/A
9/30/2016	3,769	2,115	N/A	1,155	N/A
6/30/2016	3,661	1,951	N/A	1,237	N/A
3/31/2016	3,658	2,131	N/A	1,056	N/A
12/31/2015	3,529	2,131	N/A	864	N/A
9/30/2015	3,432	1,575	N/A	1,057	N/A
6/30/2015	3,281	1,390	N/A	830	N/A
3/31/2015	3,112	1,276	N/A	830	N/A
12/31/2014	3,076	1,253	N/A	881	N/A
12/31/2013	2,897	948	N/A	540	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (46.3% al año) de PNDX B es superior a la tasa de ahorro (0.9%).

Beneficios vs. Mercado: Se prevé que los beneficios (46.3% al año) de PNDX B crezcan más rápidamente que el mercado Swedish (13.1% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de PNDX B crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (2.6% al año) de PNDX B crezcan más rápidamente que los del mercado Swedish (1.4% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 2.6% al año) de PNDX B crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de PNDX B se prevé que sea elevada dentro de 3 años.

Pandox Crecimiento futuro

Future controles de criterios 4/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Consensus EPS estimates fall by 13%

Consensus EPS estimates fall by 31%

Price target decreased by 13% to kr143

Consensus EPS estimates fall by 12%

Consensus EPS estimates increase by 44%

Consensus forecasts updated

Recent updates

Some Investors May Be Willing To Look Past Pandox's (STO:PNDX B) Soft Earnings

First quarter 2024 earnings released

An unknown buyer completed the acquisition of DoubleTree by Hilton Montreal from Pandox AB (publ) (OM:PNDX B).

Pandox AB (Publ) Approves Dividend

Upcoming dividend of kr4.00 per share

Pandox's (STO:PNDX B) Dividend Will Be Increased To SEK4.00

Full year 2023 earnings: EPS misses analyst expectations

Dividend increased to kr4.00

Pandox AB (publ) to Report Fiscal Year 2023 Results on Mar 08, 2024

Pandox AB (publ) Proposes a Dividend

Full year 2023 earnings: EPS misses analyst expectations

We Think Pandox (STO:PNDX B) Is Taking Some Risk With Its Debt

Pandox AB (publ) to Report Fiscal Year 2024 Results on Feb 06, 2025

Third quarter 2023 earnings released: EPS: kr2.48 (vs kr9.16 in 3Q 2022)

Pandox (STO:PNDX B) Takes On Some Risk With Its Use Of Debt

Pandox AB (publ), Annual General Meeting, Apr 10, 2024

Consensus EPS estimates fall by 13%

New minor risk - Profit margin trend

Second quarter 2023 earnings: Revenues exceed analyst expectations

Consensus EPS estimates fall by 31%

Does Pandox (STO:PNDX B) Have A Healthy Balance Sheet?

Price target decreased by 13% to kr143

Insider recently bought kr895k worth of stock

First quarter 2023 earnings: Revenues miss analyst expectations

Less than half of directors are independent

Upcoming dividend of kr2.50 per share at 2.0% yield

Key Executive recently bought kr536k worth of stock

With EPS Growth And More, Pandox (STO:PNDX B) Makes An Interesting Case

Insider recently bought kr429k worth of stock

Chief Commercial Officer recently bought kr282k worth of stock

Chief Executive Officer recently bought kr490k worth of stock

Consensus EPS estimates fall by 12%

Full year 2022 earnings: EPS and revenues miss analyst expectations

Pandox AB (publ) Proposes Dividend for 2022

An unknown buyer acquired InterContinental from Montreal Pandox AB (publ) (OM:PNDX B) for CAD 80 million.

Is Now An Opportune Moment To Examine Pandox AB (publ) (STO:PNDX B)?

Pandox AB (publ) to Report Fiscal Year 2022 Results on Mar 10, 2023

Second quarter 2022 earnings released: EPS: kr7.45 (vs kr0.038 loss in 2Q 2021)

Consensus EPS estimates increase by 44%

Industry Analysts Just Upgraded Their Pandox AB (publ) (STO:PNDX B) Revenue Forecasts By 16%

Pandox AB (publ) to Report Fiscal Year 2022 Results on Feb 10, 2023

Is Pandox (STO:PNDX B) Using Too Much Debt?

Pandox AB (publ) (OM:PNDX B) acquired Hotel in the UK from Starwood Capital Operations, LLC for £40 million.

Pandox AB (publ) Announces Nomination Committee for the AGM 2023

Pandox AB (publ) (OM:PNDX B) agreed to acquire NH Brussels Louise in central Brussels from NH Hotel Group, S.A. (BME:NHH).

Consensus forecasts updated

Investor sentiment improved over the past week

Price target increased to kr168

Second quarter 2022 earnings: Revenues exceed analyst expectations

Pandox AB (publ), Annual General Meeting, Apr 12, 2023

Pandox AB (Publ) Announces Executive Changes

We Think Pandox (STO:PNDX B) Is Taking Some Risk With Its Debt

Pandox AB (publ) to Report Fiscal Year 2023 Results on Feb 08, 2024

Director recently bought kr401k worth of stock

First quarter 2022 earnings: Revenues miss analyst expectations

Consensus EPS estimates fall by 28%

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Pandox AB (publ) to Report Fiscal Year 2021 Results on Mar 11, 2022

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Analysts Just Made A Stunning Upgrade To Their Pandox AB (publ) (STO:PNDX B) Forecasts

Consensus revenue estimates increase by 37%

Consensus EPS estimates fall by 20%

Pandox (STO:PNDX B) Has A Somewhat Strained Balance Sheet

Third quarter 2021 earnings released

Price target increased to kr158

Pandox (STO:PNDX B) Use Of Debt Could Be Considered Risky

Price target increased to kr153

Second quarter 2021 earnings released: kr0.04 loss per share (vs kr1.79 loss in 2Q 2020)

Pandox (STO:PNDX B) May Have Issues Allocating Its Capital